Literature DB >> 7590444

Vasoactive mediators and the progression from oedematous to necrotising experimental acute pancreatitis.

H Weidenbach1, M M Lerch, T M Gress, D Pfaff, S Turi, G Adler.   

Abstract

Little is known about the pathophysiological factors that determine the clinical severity of acute pancreatitis. Because impairment of pancreatic circulation and oxygenation is associated with greater disease severity and morphological damage in experimental pancreatitis it has been suggested that various vasoactive mediators might participate in the progression from the oedematous to the necrotising variety of the disease. This study used an animal model of acute pancreatitis induced by intravenous caeruleint (10 micrograms/kg/h for up to six hours), which does not entail either haemorrhage or significant necrosis of the pancreas. This study considered whether the administration or the inhibition of either nitric oxide, bradykinin, or adrenergic mediators can convert this mild variety into haemorrhagic and necrotising pancreatitis. Neither nitric oxide nor catecholamines were involved in the progression from oedematous to haemorrhagic pancreatitis. Their substitution, activation, and inhibition all failed to change the severity of the disease process. Bradykinin alone seemed to be critically involved in the pathogenesis of pancreatic haemorrhage and necrosis. However, the inhibition of bradykinin and not its activation or substitution increased the severity of the disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590444      PMCID: PMC1382829          DOI: 10.1136/gut.37.3.434

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  26 in total

1.  Subcellular redistribution of lysosomal enzymes during caerulein-induced pancreatitis.

Authors:  A Saluja; S Hashimoto; M Saluja; R E Powers; J Meldolesi; M L Steer
Journal:  Am J Physiol       Date:  1987-10

Review 2.  Kinins--possible physiologic and pathologic roles in man.

Authors:  R W Kellermeyer; R C Graham
Journal:  N Engl J Med       Date:  1968-10-17       Impact factor: 91.245

3.  Kininase activity in experimental pancreatitis.

Authors:  F W Nugent; W A Atendido; M B Bulan; A J MacDonald
Journal:  Nature       Date:  1966-07-09       Impact factor: 49.962

4.  Does stress play a role in the development of severe pancreatitis in rats?

Authors:  H Yamaguchi; T Kimura; H Nawata
Journal:  Gastroenterology       Date:  1990-06       Impact factor: 22.682

5.  Vasoactive drugs, microvascular permeability, and hemorrhagic pancreatitis in cats.

Authors:  M H Harvey; K R Wedgwood; H A Reber
Journal:  Gastroenterology       Date:  1987-12       Impact factor: 22.682

6.  In vivo rat pancreatic acinar cell function during supramaximal stimulation with caerulein.

Authors:  A Saluja; I Saito; M Saluja; M J Houlihan; R E Powers; J Meldolesi; M Steer
Journal:  Am J Physiol       Date:  1985-12

7.  Three-dimensional morphological study of the pancreatic microvasculature in caerulein-induced experimental pancreatitis.

Authors:  G McEntee; A Leahy; D Cottell; P Dervan; K McGeeney; J M Fitzpatrick
Journal:  Br J Surg       Date:  1989-08       Impact factor: 6.939

8.  Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies.

Authors:  K Wirth; F J Hock; U Albus; W Linz; H G Alpermann; H Anagnostopoulos; S Henk; G Breipohl; W König; J Knolle
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

9.  Changes in the kallikrein kinin system during acute pancreatitis in man.

Authors:  A Lasson; K Ohlsson
Journal:  Thromb Res       Date:  1984-07-01       Impact factor: 3.944

10.  Fatal acute pancreatitis.

Authors:  C Wilson; C W Imrie; D C Carter
Journal:  Gut       Date:  1988-06       Impact factor: 23.059

View more
  27 in total

1.  Nitric oxide protects the ultrastructure of pancreatic acinar cells in the course of caerulein-induced acute pancreatitis.

Authors:  A Andrzejewska; G Jurkowska
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

2.  Combined treatment with C1 esterase inhibitor and antithrombin III improves survival in severe acute experimental pancreatitis.

Authors:  H Yamaguchi; H Weidenbach; H Lührs; M M Lerch; G Dickneite; G Adler
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

3.  Different effects of dexamethasone and the nitric oxide synthase inhibitor L-NAME on caerulein-induced rat acute pancreatitis, depending on the severity.

Authors:  Yusuke Sugiyama; Shinichi Kato; Mitsumasa Abe; Shoji Mitsufuji; Koji Takeuchi
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

4.  Pathogenic role of endothelial nitric oxide synthase (eNOS/NOS-III) in cerulein-induced rat acute pancreatitis.

Authors:  Yusuke Sugiyama; Shinichi Kato; Shoji Mitsufuji; Takeshi Okanoue; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2006-07-13       Impact factor: 3.199

Review 5.  Etiology and Risk Factors of Acute and Chronic Pancreatitis.

Authors:  Frank Ulrich Weiss; Felix Laemmerhirt; Markus M Lerch
Journal:  Visc Med       Date:  2019-03-13

Review 6.  Severe acute pancreatitis: pathogenetic aspects and prognostic factors.

Authors:  Ibrahim-A Al Mofleh
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

7.  Kallikrein inhibitors limit kinin B(2) antagonist-induced progression of oedematous to haemorrhagic pancreatitis in rats.

Authors:  T Griesbacher; I Rainer; B Tiran; B A Peskar
Journal:  Br J Pharmacol       Date:  2008-08-11       Impact factor: 8.739

8.  Endothelin receptor blockade improves fluid sequestration, pancreatic capillary blood flow, and survival in severe experimental pancreatitis.

Authors:  T Foitzik; J Faulhaber; H G Hotz; M Kirchengast; H J Buhr
Journal:  Ann Surg       Date:  1998-11       Impact factor: 12.969

9.  Mechanism of kinin release during experimental acute pancreatitis in rats: evidence for pro- as well as anti-inflammatory roles of oedema formation.

Authors:  Thomas Griesbacher; Irmgard Rainer; Beate Tiran; Edwin Fink; Fred Lembeck; Bernhard A Peskar
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

10.  Nitric oxide pathways and evidence-based perturbations in acute pancreatitis.

Authors:  Matthew J DiMagno
Journal:  Pancreatology       Date:  2007-09-25       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.